Clinical trials
Amyotrophic Lateral Sclerosis trials in the United States with no applicable phase
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
80 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2004 | 2 |
| 2007 | 1 |
| 2008 | 2 |
| 2009 | 1 |
| 2010 | 3 |
| 2012 | 4 |
| 2013 | 4 |
| 2015 | 3 |
| 2016 | 3 |
| 2017 | 6 |
| 2018 | 4 |
| 2019 | 3 |
| 2020 | 2 |
| 2021 | 6 |
| 2022 | 3 |
| 2023 | 5 |
| 2024 | 7 |
| 2025 | 8 |
| 2026 | 12 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 36 |
| Recruiting | 26 |
| Terminated | 6 |
| Unknown status | 3 |
| Not yet recruiting | 3 |
| Withdrawn | 2 |
| Enrolling by invitation | 2 |
| Active, not recruiting | 2 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Johns Hopkins University | 6 |
| University of Michigan | 6 |
| Cognixion | 3 |
| Leigh R. Hochberg, MD, PhD. | 3 |
| Neuralink Corp | 3 |
| Nova Southeastern University | 3 |
| Penn State University | 3 |
| VA Office of Research and Development | 3 |
| Bronx VA Medical Center | 2 |
| Columbia University | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Amyotrophic Lateral Sclerosis | 80 |
| Spinal Cord Injuries | 18 |
| Quadriplegia | 13 |
| Stroke | 10 |
| Brain Stem Infarctions | 9 |
| Muscular Dystrophies | 9 |
| Locked-In Syndrome | 7 |
| Dysarthria | 6 |
| Motor Neuron Disease | 6 |
| Paralysis | 6 |
Trials
Showing 1 to 25 of 80. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.